- Home
- RCKT vs FINS Comparison
RCKT vs FINS Comparison
Compare RCKT & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCKT | FINS |
|---|---|---|
| Founded | 1999 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.6M | 436.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RCKT | FINS |
|---|---|---|
| Price | $3.65 | $13.20 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.12 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 78.0K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.19 | $11.61 |
| 52 Week High | $11.45 | $12.57 |
Technical Indicators
Market Signals| Indicator | RCKT | FINS |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 51.78 |
| Support Level | $3.47 | $13.16 |
| Resistance Level | $3.98 | $13.34 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 44.93 | 60.59 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.